arrow
K

Katsuyuki Kiura

Okayama University Hospital
H指数:64
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Limited Immune-Mediated Efficacy of Anti-PD-L1/VEGF in EGFR-TKI-Naïve Egfr-Mutant Lung Cancer with Non-Inflamed Tumor Microenvironment

在非炎症性肿瘤微环境中,EGFR-TKI初治的EGFR突变型肺癌中抗PD-L1/VEGF的有限免疫介导疗效

2026-05-280
OAAI
Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr-mutated lung cancer

干扰素基因刺激物激动剂增强了奥希替尼在EGFR突变型肺癌中的抗肿瘤免疫作用

2026-05-210
OAAI
Incidence and clinical features of venous thromboembolism in patients with lung cancer in Japan: results from the CS-Lung-003 prospective observational registry study

日本肺癌患者中静脉血栓栓塞症的发病率和临床特征:CS-Lung-003前瞻性观察性登记研究的结果

2025-11-010
OAAI
Five-year outcomes with gefitinib induction and chemoradiotherapy in EGFR-mutant stage III non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study

吉非替尼诱导联合化放疗在EGFR突变型III期非小细胞肺癌中的五年结果:LOGIK0902/OLCSG0905 II期研究

2025-02-050
OA
Plasma S100A8/A9 level predicts response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer

血浆S100A8/A9水平预测晚期非小细胞肺癌患者对免疫检查点抑制剂的反应

2025-01-200
OAAI
A novel molecular target, superoxide dismutase 1, in ALK inhibitor-resistant lung cancer cells, detected through proteomic analysis

通过蛋白质组学分析在ALK抑制剂耐药的肺癌细胞中检测到一个新的分子靶标,超氧化物歧化酶1

2024-10-010
PRE
Efficacy of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Metastatic Non-Small Cell Lung Cancer Patients with Poor Performance Status and Epidermal Growth Factor Receptor Mutations: Findings from the Japanese Cancer Database

表皮生长因子受体-酪氨酸激酶抑制剂对伴有表皮生长因子受体突变的转移性非小细胞肺癌患者的疗效: 来自日本癌症数据库的发现

2024-06-012
OAAI
Impacts of probiotics on the efficacies of immune checkpoint inhibitors with or without chemotherapy for patients with advanced non-small-cell lung cancer
2024-01-095
PRE
CDK4/6 signaling attenuates the effect of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer
2023-10-012
OAAI
Low frequency of intracranial progression in advanced NSCLC patients treated with cancer immunotherapies

接受癌症免疫疗法治疗的晚期NSCLC患者颅内进展的低频率

2023-08-232
OA
Epidemiology, risk factors and impact of cachexia on patient outcome: Results from the Japanese Lung Cancer Registry Study

流行病学,危险因素和恶病质对患者预后的影响: 来自日本肺癌注册研究的结果

2023-03-1022
OA